Protalix Biotherapeutics Inc banner
P

Protalix Biotherapeutics Inc
AMEX:PLX

Watchlist Manager
Protalix Biotherapeutics Inc
AMEX:PLX
Watchlist
Price: 2.86 USD -2.05% Market Closed
Market Cap: $230m

Wall Street
Price Targets

PLX Price Targets Summary
Protalix Biotherapeutics Inc

Wall Street analysts forecast PLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.

Lowest
Price Target
10.1 USD
253% Upside
Average
Price Target
11.22 USD
292% Upside
Highest
Price Target
12.6 USD
341% Upside
Protalix Biotherapeutics Inc Competitors:
Price Targets
ARDX
Ardelyx Inc
114% Upside
0HQ1
Brooks Automation Inc
47% Upside
LGI
Lgi Ltd
45% Upside
VAC
Pierre et Vacances SA
28% Upside

Revenue
Forecast

25% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
25% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

N/A
Past Growth
59% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
N/A
Past Growth
59% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 59%.

Net Income
Forecast

N/A
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss
N/A
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss

The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 74%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PLX's stock price target?
Price Target
11.22 USD

According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.

What is Protalix Biotherapeutics Inc's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 10%.

What is Protalix Biotherapeutics Inc's Operating Income forecast?
Projected CAGR
59%

The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 59%.

What is Protalix Biotherapeutics Inc's Net Income forecast?
Projected CAGR
74%

The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 74%.

Back to Top